Keywords: dyax, gets, green, light, fda, resume, dx-88

Dyax gets green light from FDA to resume DX-88 trials

Article | 14 June 2004

Print This

Massachusetts, USA-based Dyax Corp has been given the go-ahead by the US Food and Drug Administration to proceed with Phase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in